These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10602738)

  • 1. Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies.
    Hvidberg H; Struve C; Krogfelt KA; Christensen N; Rasmussen SN; Frimodt-Møller N
    Antimicrob Agents Chemother; 2000 Jan; 44(1):156-63. PubMed ID: 10602738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model.
    Kerrn MB; Frimodt-Møller N; Espersen F
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1002-9. PubMed ID: 12604534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.
    Hagberg L; Engberg I; Freter R; Lam J; Olling S; Svanborg Edén C
    Infect Immun; 1983 Apr; 40(1):273-83. PubMed ID: 6339403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crude polysaccharides from the seeds of Vaccaria segetalis prevent the urinary tract infection through the stimulation of kidney innate immunity.
    Mao X; Guo H; Yao R; Bao L; Sun J; Bao Y; Guo B; Gao Y; Shi Y; Zhang H; Cui X
    J Ethnopharmacol; 2020 Oct; 260():112578. PubMed ID: 31962152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
    Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
    J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viable but nonculturable uropathogenic bacteria are present in the mouse urinary tract following urinary tract infection and antibiotic therapy.
    Rivers B; Steck TR
    Urol Res; 2001 Feb; 29(1):60-6. PubMed ID: 11310218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection.
    Roldan-Masedo E; Sainz T; Gutierrez-Arroyo A; Gomez-Gil RM; Ballesteros E; Escosa L; Baquero-Artigao F; Méndez-Echevarría A
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2097-2102. PubMed ID: 31359255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.
    Michaud JE; Kim KS; Harty W; Kasprenski M; Wang MH
    BMC Microbiol; 2017 May; 17(1):127. PubMed ID: 28545489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in cell division among anatomical sites shapes Escherichia coli antibiotic survival in a urinary tract infection mouse model.
    Amoura A; Pistien C; Chaligné C; Dion S; Magnan M; Bridier-Nahmias A; Baron A; Chau F; Bourgogne E; Le M; Denamur E; Ingersoll MA; Fantin B; Lefort A; El Meouche I
    Cell Host Microbe; 2024 Jun; 32(6):900-912.e4. PubMed ID: 38759643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin Pharmacokinetics/Pharmacodynamics against Susceptible and Low-Level Resistant Escherichia coli Isolates in an Experimental Ascending Urinary Tract Infection Model in Mice.
    Jakobsen L; Lundberg CV; Frimodt-Møller N
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33106267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli.
    Chang UI; Kim HW; Wie SH
    Korean J Intern Med; 2016 Jan; 31(1):145-55. PubMed ID: 26767868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
    Süzük S; Kaşkatepe B; Avcıküçük H; Aksaray S; Başustaoğlu A
    Mikrobiyol Bul; 2015 Oct; 49(4):494-501. PubMed ID: 26649407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection.
    Kalas V; Hibbing ME; Maddirala AR; Chugani R; Pinkner JS; Mydock-McGrane LK; Conover MS; Janetka JW; Hultgren SJ
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2819-E2828. PubMed ID: 29507247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.
    Håversen LA; Engberg I; Baltzer L; Dolphin G; Hanson LA; Mattsby-Baltzer I
    Infect Immun; 2000 Oct; 68(10):5816-23. PubMed ID: 10992490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Escherichia coli phylogenetic group B2 with integrons prevails in childhood recurrent urinary tract infections.
    Kõljalg S; Truusalu K; Stsepetova J; Pai K; Vainumäe I; Sepp E; Mikelsaar M
    APMIS; 2014 May; 122(5):452-8. PubMed ID: 24033434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and Pharmacodynamics of Fosfomycin and Its Activity against Extended-Spectrum-β-Lactamase-, Plasmid-Mediated AmpC-, and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model.
    Zykov IN; Samuelsen Ø; Jakobsen L; Småbrekke L; Andersson DI; Sundsfjord A; Frimodt-Møller N
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic herbal therapy prevents experimental ascending urinary tract infection in mice.
    Tong YQ; Sun M; Chi Y
    Chin J Integr Med; 2016 Oct; 22(10):774-7. PubMed ID: 27435291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo detection of Escherichia coli type 1 fimbrial expression and phase variation during experimental urinary tract infection.
    Struve C; Krogfelt KA
    Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2683-90. PubMed ID: 10537190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic-microbiologic correlates of invasiveness in a mouse model of ascending unobstructed urinary tract infection.
    Johnson JR; Berggren T; Manivel JC
    J Infect Dis; 1992 Feb; 165(2):299-305. PubMed ID: 1730896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.